Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial
2018 ◽
Vol 5
(1)
◽
pp. e34-e43
◽
2020 ◽
Vol 7
(8)
◽
pp. e566-e574
◽
2018 ◽
Vol 19
(12)
◽
pp. 1668-1679
◽
2015 ◽
Vol 16
(16)
◽
pp. 1691-1699
◽